Rika Suda

574 total citations
39 papers, 372 citations indexed

About

Rika Suda is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Rika Suda has authored 39 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 20 papers in Cardiology and Cardiovascular Medicine and 7 papers in Genetics. Recurrent topics in Rika Suda's work include Pulmonary Hypertension Research and Treatments (31 papers), Cardiovascular Function and Risk Factors (8 papers) and Vascular Anomalies and Treatments (7 papers). Rika Suda is often cited by papers focused on Pulmonary Hypertension Research and Treatments (31 papers), Cardiovascular Function and Risk Factors (8 papers) and Vascular Anomalies and Treatments (7 papers). Rika Suda collaborates with scholars based in Japan and Netherlands. Rika Suda's co-authors include Koichiro Tatsumi, Seiichiro Sakao, Nobuhiro Tanabe, Ayumi Sekine, Rintaro Nishimura, Takayuki Jujo, Toshihiko Sugiura, Akira Naito, Ayako Shigeta and Fumiaki Kato and has published in prestigious journals such as PLoS ONE, Journal of Thoracic and Cardiovascular Surgery and American Journal of Respiratory Cell and Molecular Biology.

In The Last Decade

Rika Suda

36 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rika Suda Japan	12	266	135	102	54	44	39	372
Ayumi Sekine Japan	11	291 1.1×	145 1.1×	109 1.1×	55 1.0×	32 0.7×	36	401
Katsuya Kozu Japan	9	263 1.0×	198 1.5×	58 0.6×	67 1.2×	25 0.6×	16	350
Fu-Hua Peng China	10	251 0.9×	141 1.0×	63 0.6×	34 0.6×	17 0.4×	27	351
Xi-Qi Xu China	10	195 0.7×	179 1.3×	123 1.2×	25 0.5×	40 0.9×	28	392
Gregory Elliott United States	7	288 1.1×	115 0.9×	33 0.3×	60 1.1×	39 0.9×	10	324
David Kylhammar Sweden	13	638 2.4×	441 3.3×	56 0.5×	111 2.1×	47 1.1×	22	710
Anqi Duan China	10	111 0.4×	78 0.6×	51 0.5×	11 0.2×	44 1.0×	42	237
Jai Prakash Muyal India	9	149 0.6×	73 0.5×	100 1.0×	17 0.3×	78 1.8×	16	315
Silvia Rain Netherlands	7	515 1.9×	482 3.6×	76 0.7×	20 0.4×	29 0.7×	9	635
C. François France	3	290 1.1×	192 1.4×	64 0.6×	25 0.5×	20 0.5×	9	366

Countries citing papers authored by Rika Suda

Since Specialization

Citations

This map shows the geographic impact of Rika Suda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rika Suda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rika Suda more than expected).

Fields of papers citing papers by Rika Suda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rika Suda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rika Suda. The network helps show where Rika Suda may publish in the future.

Co-authorship network of co-authors of Rika Suda

This figure shows the co-authorship network connecting the top 25 collaborators of Rika Suda. A scholar is included among the top collaborators of Rika Suda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rika Suda. Rika Suda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ishida, Keiichi, Yuji Nishimoto, Hiroyuki Ohbe, et al.. (2025). Short-term outcomes of thrombolysis versus surgical pulmonary embolectomy in patients with high-risk pulmonary embolism. Journal of Thoracic and Cardiovascular Surgery. 171(2). 410–418.e4. 1 indexed citations

Nakagami, Tomoko, Yukiko Hasegawa, Yuichiro Kondo, et al.. (2024). Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes. Diabetology International. 15(2). 237–243. 4 indexed citations

Tamura, Yuichi, Hiraku Kumamaru, Ichizo Tsujino, et al.. (2024). Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study). Pharmaceuticals. 17(5). 555–555.

Takeda, Kenichiro, Takeshi Inagaki, Akira Naito, et al.. (2024). The utility and safety of one-minute sit-to-stand test in pulmonary hypertension: A prospective study. Respiratory Investigation. 63(1). 61–66. 2 indexed citations

Ishida, Keiichi, Hiroki Kohno, Kaoru Matsuura, et al.. (2023). Impact of residual pulmonary hypertension on long‐term outcomes after pulmonary endarterectomy in the modern era. Pulmonary Circulation. 13(2). e12215–e12215. 3 indexed citations

Jujo, Takayuki, Koji Hosomi, Jonguk Park, et al.. (2022). Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan. BMC Pulmonary Medicine. 22(1). 138–138. 20 indexed citations

Tamura, Yuichi, Hiraku Kumamaru, Takumi Inami, et al.. (2022). Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan. JACC Asia. 2(3). 273–284. 13 indexed citations

Ishida, Keiichi, Hiroki Kohno, Kaoru Matsuura, et al.. (2022). Modification of pulmonary endarterectomy to prevent neurologic adverse events. Surgery Today. 53(3). 369–378. 1 indexed citations

Yamamoto, Keiko, Nobuhiro Tanabe, Yukiko Takahashi, et al.. (2021). Characteristics of patients meeting the new definition of pre-capillary pulmonary hypertension (Nice 2018) in a single Japanese pulmonary hypertension center. BMC Pulmonary Medicine. 21(1). 260–260. 3 indexed citations

10.

Suda, Rika, Hajime Kasai, Toshihiko Sugiura, et al.. (2021). Heritable pulmonary arterial hypertension complicated by multiple pulmonary arteriovenous malformations. Respiratory Medicine Case Reports. 32. 101352–101352. 2 indexed citations

11.

Takahashi, Yukiko, Keiko Yamamoto, Seiichiro Sakao, et al.. (2021). The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan. BMC Pulmonary Medicine. 21(1). 89–89. 6 indexed citations

12.

Naito, Akira, Takayuki Jujo, Nobuhiro Tanabe, et al.. (2021). Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment. BMC Pulmonary Medicine. 21(1). 407–407. 7 indexed citations

13.

Tamura, Yuichi, Kohtaro Abe, Ayumi Goda, et al.. (2020). Psychometric Validation of a Japanese Version of the emPHasis-10 Questionnaire, a Patient-Reported Outcome Measure for Pulmonary Hypertension　― Multicenter Study in Japan ―. Circulation Reports. 2(4). 255–259. 8 indexed citations

14.

Takahashi, Yukiko, Keiko Yamamoto, Nobuhiro Tanabe, et al.. (2019). Characteristics of Japanese elderly patients with pulmonary arterial hypertension. Pulmonary Circulation. 10(3). 1–13. 3 indexed citations

15.

Yamamoto, Keiko, Rintaro Nishimura, Fumiaki Kato, et al.. (2019). Protective role of endothelial progenitor cells stimulated by riociguat in chronic thromboembolic pulmonary hypertension. International Journal of Cardiology. 299. 263–270. 10 indexed citations

16.

Jujo, Takayuki, Seiichiro Sakao, Akira Naito, et al.. (2019). Characterization of pulmonary intimal sarcoma cells isolated from a surgical specimen: In vitro and in vivo study. PLoS ONE. 14(3). e0214654–e0214654. 3 indexed citations

17.

Tanaka, Nozomi, Takayuki Jujo, Toshihiko Sugiura, et al.. (2018). Partial anomalous pulmonary venous return with dual drainage to the superior vena cava and left atrium with pulmonary hypertension. Respiratory Medicine Case Reports. 25. 112–115. 1 indexed citations

18.

Yamamoto, Keiko, Nobuhiro Tanabe, Rika Suda, et al.. (2017). Riociguat for patients with chronic thromboembolic pulmonary hypertension: Usefulness of transitioning from phosphodiesterase type 5 inhibitor. Respiratory Investigation. 55(4). 270–275. 14 indexed citations

19.

Nishimura, Rintaro, Nobuhiro Tanabe, Ayumi Sekine, et al.. (2016). Synergistic Effects of ACE Insertion/Deletion and GNB3 C825T Polymorphisms on the Efficacy of PDE-5 Inhibitor in Patients with Pulmonary Hypertension. Respiration. 91(2). 132–140. 6 indexed citations

20.

Kawasaki, Takeshi, Tetsu Nishiwaki, Ayumi Sekine, et al.. (2015). Vascular Repair by Tissue-Resident Endothelial Progenitor Cells in Endotoxin-Induced Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 53(4). 500–512. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact